Description: The article is about everfi login. EVERFI gathered experts to discuss the opioid crisis’ impact on the nation’s schools and colleges. Conversations addressed the steps family members, physicians, schools and public health officials can take to curb opioid addiction within the younger population.
It’s time for the sponsor perspective portion of our program. For this next conversation, I’d like to invite Daniel Miller, he is the senior vice president of pharmacy regulatory affairs at Rite Aid, I’d like to invite Elizabeth Campbell, she is senior vice president and group general counsel at Amaris Bergen, I’d like to invite Chester Davis, he is the president and CEO of the association for accessible medicines.
Thank you for being with us this morning, everfi is so honored to sponsor this opportunity for an important conversation about what is happening in our communities. As a leading education technology organization, we have been at the crossroads of prevention education at a population level for more than a decade.
About a year ago, we began to take that work and create what is now known as the prescription drug safety Network, we began to look out on the scene and recognize that there was a ton of data and information upstream about rescue and treatment, there was very little networking of us coming together across our communities and looking at what truly prevention education might look like.
We created the prevention and the prescription drug safety network with that prevention in mind. I’m proud that a year later, we have more than 20 organizations across the ecosystem that are now coming together in an effort to create prevention education in our country. We have three organizations in that ecosystem that are all doing different pieces and want you to be able to have that conversation of what that looks like in your different world.
Let me start with you. What a comprehensive strategy should look like? What are you currently working on? A comprehensive strategy involves retail pharmacy, but it also involves advocacy groups, healthcare professionals even law enforcement and law makers most importantly, we all have to collaborate and communicate together to make sure that we execute on some workable options in a serious situation.
I’m a pharmacist, I know what a pharmacist knowledge base is, they’re so accessible within the community to help around medication, they know what the therapeutic benefits are for medicines, they also know what the adverse effects are and what the combination therapies are and concerns around those, they have great source within the community.
We have to make sure that we use these individuals. We have a responsibility to write the ongoing training for our pharmacists to get familiar with Opioids, Suboxone and Naloxone, our pharmacists are trained to provide that to patients, caregivers and family members and explain how that works.
We also support the CDC guidelines that talk about making sure that we have some limits in place for acute medication dispensing and control that in some cases.
We will make sure that our pharmacists have an encounter with every patient that gets an Opioid prescription, we continue to upgrade our systems to make it easier for the pharmacist and the patient, they will get a little leaflet that explains what the medications for so that they can understand how serious this medicine is and what means to take this and what they should do once the pain subsides.
We also talked about the fact in the lock zone, we work at the point of engagement within the stores and the patients, that is obviously very critical to us. We have the resource of the prescription drug monitoring program which lets our pharmacists go out and assess some patients that they maybe don’t know what will come to their pharmacy frequently.
They can see the shopping multiple pharmacies or multiple prescribers to help make the right professional decision and talk that over with the patient prescriber if necessary, those are some of the activities within the store.
We also reach out within the community and we’re very proud of this, we have a Rite Aid Foundation that has committed money for different reasons, we put in a medication disposal system within law enforcement, we went to 18 states, we have a robust website that law enforcement can sign one and get them within their police station.
We fully fund that so that they have the ability to take care of the individuals within the community to dispose of the medicine. For the sake of everFi, we’ve done very well an education tool. We can go out into the high school systems and educate our youth and make sure that they’re aware of the concerns on these medicines very early and address some of the issues.
It has been great for this partnership and we hope that collaboration will help us expand this network so that we can do more things within the community. What does a strategy look like from your approach? First of all, I am going to explain about who Maris Bergen is.
Maris Bergen is a wholesaler and a logistics provider, that means that we take fda-approved medication from manufacturers and we provide that to pharmacies who will dispense that medication pursuant to valid prescription.
First of all, it is important for people to understand our role in the supply chain, we have a very unique role. Our approach is multifaceted, it’s multi-pronged, we think that collaboration is incredibly important, no one can do this alone, we need to do it together, we believe that states and the federal government must collaborate.
One of the challenges that the wholesalers have had in the past is the limited availability of data, we’ve been advocating for greater sharing of data across the industry. We have a multi-faceted approach. Someone mentioned safe disposal earlier today, several people have mentioned that disposal can be a problem, there are a lot of drugs that are remaining in people’s medicine cabinets and people don’t know what to do with them so those are taken and abused.
We’ve been partnering through our foundation to provide drug take-back and deactivation bags to municipalities. We’ve also partnered with everFi through the foundation, we have a program in Ohio where we’re providing education about prevention and abuse to middle school students.
We’re also excited that we are going to do a new additional program in Florida. Chip is our first partner in the prescription drug safety network, you’re focused on colleges, you should talk about what you think the comprehensive solution looks like for your members.
I think what you’ve heard on this panel is the importance of an all-in approach. We didn’t get there overnight, it’s going to take the collective effort of everybody within the system that includes industry, there are a lot of talks about provider education and training and greater awareness.
We felt that there is not as much of a focus on patient education and awareness and potential patient education and awareness over a year ago., that’s an important distinction as well. I work for the Association for accessible medicines by way of background, we represent generic and biosimilar manufacturers, our commitment is very simple.
We want to make sure that patients have access to safe effective and affordable medicines. Our members are providing 89% of all prescriptions around the United States but doing it for only one-quarter of total cost. We’re big believers, we are making sure that patients have access to medicine. Increasingly within this epidemic, we also want to make sure that there is not inappropriate access to medicine, we need to reduce the misuse.
Having a working relationship with everFi and knowing that their core competency and excellence are in some things such as sexual assault, prevention abuse and an alcohol abuse on college campuses, we thought there would be an opportunity to develop a similar program online and make it available to incoming college freshmen.
The reality is an unbelievable amount of autonomy at that time, that creates opportunity, but it also creates some vulnerability, there was a study done in 2015 that showed that more than one out of every 10 college students had admitted that they were using pain medicines for non-medical reasons.
We developed this online module to leverage the intellectual capital and expertise of everFi and offer it free to colleges and universities across the country. We started that with incoming freshmen because of the vulnerability, tens of thousands of this started this fall.
You’ve heard others have joined into the program which is great because incoming college freshmen are not the only vulnerable population. One of the things that we also need to make sure of moving forward is that the training module is putting into practice, there are metrics associated with the online program, 75% of the the students have taken it.
They are better equipped to know the signs and be aware that they may have a friend or a colleague or somebody who will concern about that. It is empowering them to understand on their own college or university campus where they can go if they’re impacted by this or where they can go and seek help for somebody that they care about. It has been a important partnership.
When I speak at other events such as in front of the attorneys general or governor’s associations, there are a lot of talks on the system level about drug costs. We have a lot of discussions around that, we make sure that when we’re talking to government officials, we can let them know about this program because it’s free to the colleges and universities in their home state.
We ask them to be ambassadors and take this back home and make sure that the awareness of this program is available to the University and college leaders in their states.